Instructor
Duke University
Dr. Daniel Gonzalez is a clinical pharmacologist in the Division of Clinical Pharmacology of the Department of Medicine at the Duke University School of Medicine, and a member of the Duke Clinical Research Institute. Gonzalez received his PharmD and PhD from the University of Florida College of Pharmacy in 2008 and 2012, respectively. He then completed a postdoctoral fellowship through the UNC-Duke Collaborative Clinical Pharmacology T32 Postdoctoral Training Program. Following completion of his post-doctoral training, Gonzalez served as a faculty member at the UNC Eshelman School of Pharmacy between 2014 and 2023 and transitioned to Duke University in 2023. His research interests include clinical pharmacology and applying mathematical modeling and simulation techniques to characterize the pharmacokinetics and pharmacodynamics of drugs, guide drug dosage selection, and improve drug safety. Gonzalez’s research program is funded by the Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD), and he has published >100 peer-reviewed publications and >40 abstracts. He has been the major advisor for 8 PhD students (4 completed, 4 in training) and 15 postdoctoral fellows.
Disclosure(s): Chimerix: Consultant/Advisory Board (Ongoing); Cognigen Division, Simulations Plus Inc: Consultant/Advisory Board (Ongoing); Tellus Therapeutics: Consultant/Advisory Board (Ongoing)
Equity, Data, and Representation in Real-World Clinical Trials and Virtual Populations
Thursday, March 28, 2024
11:00 AM – 12:00 PM MDT
Oral Abstract I: Assessing Drug Safety in Special Populations
Thursday, March 28, 2024
3:30 PM – 4:30 PM MDT